SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. The company is headquartered in Eden Prairie, Minnesota and currently employs 369 full-time employees. The firm operates through two segments: Medical Device and In Vitro Diagnostics. The firm’s Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The firm’s In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.